State Services
Reduce your administrative burden with our state licensing services.
SOLUTIONS
-
Life Sciences Solutions
-
Healthcare Solutions
-
Medical Device and Diagnostic
-
U.S. Government
Life Sciences Solutions
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences Solutions
Healthcare Solutions
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare Solutions
Medical Device and Diagnostic Solutions
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreMedical Device and Diagnostic Solutions
U.S. Government Solutions
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreU.S. Government Solutions
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORECase Study
Dispensary of Hope Case Study
How IQVIA's compliance solution powers health equity
Dec 20, 2022
Dispensary of Hope is a nonprofit medication distributor, focused on providing access to medication for America's most vulnerable, which reduces access disparity – a key element of health equity. This case study discusses how IQVIA helped Dispensary of Hope navigate regulatory changes after the state of Kentucky reclassified Gabapentin as a controlled substance.
Related solutions
Commercial Compliance
Simplify compliance, save your bottom line
Compliance & Quality
Navigate the challenge of compliance, and its vital association with quality